Sionna Therapeutics, Inc. (SION): EPS (Diluted)
-$1.88
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.88 | n/m | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | -$15.99 | n/a | 2026-03-02, From 2024-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | 2025-12-31 | -$1.88 | n/m |
| Omeros Corp (OMER) | 2025-12-31 | -$0.05 | n/m |
| Prothena Corp Public Ltd Co (PRTA) | 2025-12-31 | -$4.53 | n/m |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | -$1.74 | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$0.80 | n/m |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | -$1.12 | n/m |
| Rocket Pharmaceuticals, Inc. (RCKT) | 2025-12-31 | -$2.01 | n/m |
| Amylyx Pharmaceuticals, Inc. (AMLX) | 2025-12-31 | -$1.53 | n/m |
| ArriVent BioPharma, Inc. (AVBP) | 2025-12-31 | -$4.32 | n/m |
Compare SION, OMER, PRTA, SPRY side by side · Screen every company in Pharmaceutical Preparations ↗